STOCK TITAN

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Akoya Biosciences, Inc. (Nasdaq: AKYA) will release financial results for the fourth quarter and full year of 2023 on March 4th, 2024. The company will host a conference call to discuss financial results at 5:00 p.m. ET. Akoya will also be participating in the upcoming BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024.
Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on March 4th, 2024. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

Akoya will also be participating in the upcoming BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference taking place on February 13-14, 2024.

About Akoya Biosciences

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
investors@akoyabio.com

Media Contact:
Christine Quern
media@akoyabio.com


FAQ

When will Akoya Biosciences release financial results for the fourth quarter and full year of 2023?

Akoya Biosciences will release financial results for the fourth quarter and full year of 2023 on March 4th, 2024.

What time will the conference call to discuss financial results take place?

The conference call to discuss financial results will take place at 5:00 p.m. ET.

Where can investors listen to the conference call?

Investors can listen to the conference call by registering online at least a day in advance. A live and archived webcast of the event will be available on the 'Investors' section of the Akoya website at https://investors.akoyabio.com/.

What conference will Akoya Biosciences be participating in on February 13-14, 2024?

Akoya Biosciences will be participating in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024.

Akoya BioSciences, Inc.

NASDAQ:AKYA

AKYA Rankings

AKYA Latest News

AKYA Stock Data

149.59M
25.63M
11.09%
70.19%
3.24%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
MARLBOROUGH